Literature DB >> 18317952

Adrenergic differentiation and Ret expression in rat pheochromocytomas.

James F Powers1, Kristen L Picard, Abraham Nyska, Arthur S Tischler.   

Abstract

Pheochromocytomas are catecholamine-producing tumors of the adult adrenal medulla. They are rare in humans and most other species but common in laboratory rats. However, the relevance of rat pheochromocytomas as a model for their human counterparts is uncertain. Previous studies of spontaneous and drug-induced rat pheochromocytomas and the PC12 pheochromocytoma cell line suggested a distinctive noradrenergic phenotype, possibly reflecting origin from a progenitor not present in the adult human adrenal. In this study, we studied 31 pheochromocytomas derived from test and control male and female rats in toxicologic studies for expression of the epinephrine-synthesizing enzyme phenylethanolamine-N-methyltransferase (PNMT) and the receptor tyrosine kinase Ret. PNMT, which defines adrenergic chromaffin cells, is frequently expressed in human pheochromocytomas, often in tumors that also overexpress RET. We also tested for the expression of the cell cycle checkpoint protein p27(Kip1), which recently was reported absent in pheochromocytomas from a strain of rats with a hereditary mixed multiple endocrine neoplasia (MEN)-like syndrome. Using immunoblots, we demonstrated PNMT expression in almost 50% of the 31 tumors, although often at lower levels than in normal rat adrenal medulla. The majority of tumors overexpressed Ret. There was no apparent correlation between PNMT and Ret. However, in this study, PNMT expression was strongly associated with tumors arising in female rats, while overexpression of Ret did not show a sex predilection. Robust expression of p27(Kip1) was seen in all tumors from the toxicologic studies and also in a small sample of pheochromocytomas from Long-Evans rats, which were reported to have a mixed MEN-like syndrome in the 1980s. The present results show that rat pheochromocytomas have greater phenotypic diversity than previously believed and greater similarity to their human counterparts with respect to these two important markers. Loss of p27(Kip1) does not appear to account for the high frequency of pheochromocytomas in commonly utilized rat strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317952     DOI: 10.1007/s12022-008-9019-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  25 in total

1.  Nodular hyperplasia and increase of noradrenaline content in the adrenal medulla of nicotine-treated rats.

Authors:  O ERANKO
Journal:  Acta Pathol Microbiol Scand       Date:  1955

2.  Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.

Authors:  G Eisenhofer; T-T Huynh; K Pacak; F M Brouwers; M M Walther; W M Linehan; P J Munson; M Mannelli; D S Goldstein; A G Elkahloun
Journal:  Endocr Relat Cancer       Date:  2004-12       Impact factor: 5.678

3.  Pheochromocytoma.

Authors:  S Warren; R N Chute
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

4.  Up-regulation of ret by reserpine in the adult rat adrenal medulla.

Authors:  J F Powers; J M Brachold; S A Ehsani; A S Tischler
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Heide Siggelkow; Elenore Samson; Karin Bink; Heinz Höfler; Falko Fend; Jochen Graw; Michael J Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

6.  Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells.

Authors:  Lindsay Marek; Valerie Levresse; Claudia Amura; Eve Zentrich; Vicki Van Putten; Raphael A Nemenoff; Lynn E Heasley
Journal:  J Cell Physiol       Date:  2004-12       Impact factor: 6.384

7.  Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells.

Authors:  A S Tischler; L A Greene
Journal:  Adv Biochem Psychopharmacol       Date:  1980

8.  The RET proto-oncogene in sporadic pheochromocytomas.

Authors:  K Takaya; T Yoshimasa; H Arai; N Tamura; Y Miyamoto; H Itoh; K Nakao
Journal:  Intern Med       Date:  1996-06       Impact factor: 1.271

9.  Detection of ret homodimers in MEN 2A-associated pheochromocytomas.

Authors:  M Wada; N Asai; T Tsuzuki; S Maruyama; M Ohiwa; T Imai; H Funahashi; H Takagi; M Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1996-01-17       Impact factor: 3.575

10.  Expression of the c-ret proto-oncogene during mouse embryogenesis.

Authors:  V Pachnis; B Mankoo; F Costantini
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  3 in total

Review 1.  Cancer in experimental animals exposed to arsenic and arsenic compounds.

Authors:  Erik J Tokar; Lamia Benbrahim-Tallaa; Jerrold M Ward; Ruth Lunn; Reeder L Sams; Michael P Waalkes
Journal:  Crit Rev Toxicol       Date:  2010-11       Impact factor: 5.635

2.  Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma.

Authors:  Sara Molatore; Sandya Liyanarachchi; Martin Irmler; Aurel Perren; Massimo Mannelli; Tonino Ercolino; Felix Beuschlein; Barbara Jarzab; Jan Wloch; Jacek Ziaja; Saida Zoubaa; Frauke Neff; Johannes Beckers; Heinz Höfler; Michael J Atkinson; Natalia S Pellegata
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

3.  Oscillating Magnet Array-Based Nanomagnetic Gene Transfection: A Valuable Tool for Molecular Neurobiology Studies.

Authors:  Mahendran Subramanian; Aimee-Jayne Tyler; Eva Maria Luther; Elena Di Daniel; Jenson Lim; Jon Dobson
Journal:  Nanomaterials (Basel)       Date:  2017-01-29       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.